Guidance for sore throat management services
In New Zealand, rheumatic fever is a serious illness most often affecting Māori and Pacific people aged 4–19 years. It can develop after a Group A Streptococcal throat (GAS) infection. The Rheumatic Fever Prevention Programme (RFPP) is seeking to reduce the incidence of rheumatic fever. One of the ways in which it does this is by improving access to timely treatment for GAS throat infections among high-priority communities.
One component of improving access to timely treatment is the provision of free antibiotics to children and young adults with a sore throat who present to RFPP sore throat management services. The RFPP enables health professionals who do not normally have prescribing rights (eg, community health workers, nurses or pharmacists) to administer or supply specified antibiotics under specific circumstances. This ensures that sore throats can be treated quickly, without patients needing to see a doctor.
This document provides guidance for dispensing and supplying antibiotics in RFPP sore throat management services through practitioner supply orders and standing orders. Sore throat management services include school-based programmes, rapid response clinics and other clinics that are part of the RFPP.
This guidance will assist health practitioners in meeting the requirements of the Medicines Act 1981 and Medicines Regulations 1984.
Page 8: Minimum adult daily dose 1000 mg has been amended to read Maximum adult daily dose 1000 mg.
Page 9: Sore throat management service standing order: Children ≥ 30 kg: 90 mg (1,200,000 units) has been amended to read Children ≥ 30 kg: 900 mg (1,200,000 units).
Minimum adult daily dose: 1000 mg has been amended to read Maximum adult daily dose: 1000 mg